Advocating for Australia’s life sciences. The sector solving the world’s most complex health problems and powering Australia’s economic growth.
HAwdlawj;dawhldaw
awdwadaw
awdaw
As the national peak body, our responsibility is to ensure our members are supported in critical areas that drive growth, competitiveness, and long-term commercial success.
Our national platform for investor readiness, capital engagement and capital formation across Australia’s life sciences sector.
We are uniquely positioned to connect science, capability and capital through year-round programs, curated engagement and market-facing activity. AusBiotech Investment is designed to strengthen the conditions for long-term investment by improving company readiness, increasing the visibility of high-quality opportunities, and supporting more effective capital conversations across the ecosystem.
Learn more about AusBiotech Investment →
ESIF remains a cornerstone program, showcasing Australia’s most promising early-stage innovators from universities, hospitals and research institutes.
It offers researchers and pre-Series A companies the chance to deliver rapid-fire pitches to an expert panel, receiving invaluable feedback for growth and commercialisation. ESIF runs alongside AusBiotech International Conference and AusMedtech.
Learn more →
Delivered in partnership with the Australian Trade and Investment Commission (Austrade), the TradeStart Program helps Australian life sciences companies expand globally, providing expert advice, export connections, and market development support.
AusBiotech also partners with Austrade through the Trade Diversification Network to strengthen export capability and unlock new global opportunities for Australia’s life sciences sector. Combining Austrade's global reach with AusBiotech's sector expertise.
Learn more about our Trade partnerships →
AusBiotech partners with the Australian Government’s IGP to accelerate the commercialisation of innovative SMEs and start-ups, strengthen industry capability, and drive investment across Australia’s life sciences ecosystem.
Our IGP program supports companies, powering the growth of Australia’s next generation of innovators. At its core, the program is a high-impact initiative that equips innovators with the capabilities needed to confidently reach clinical, investor, and market milestones.
Learn more our IGP program →
Learn about exclusive benefits, advocacy, and networking opportunities. Connect with peers at Australia’s leading life sciences conferences, forums, and webinars through our year-round portfolio of events.